WEBULL
WebtradeDownload

Lockheed Martin (LMT) Is Investing $420 Million In Missile Production

Simply Wall St · 23h ago
  • Lockheed Martin (NYSE:LMT) announced a US$420 million expansion of its Camden, Arkansas manufacturing complex, tied to 650 new jobs.
  • The enlarged facility is planned to increase output of key missile systems used across multiple U.S. defense programs.
  • The U.S. Army reached a preliminary agreement with REalloys for a potential 75 year lease to process rare earths domestically.
  • The Camden buildout and REalloys rare earths deal only capture part of how Lockheed Martin's supply chain is changing. Take a look at 1 warning sign we have identified for Lockheed Martin.

Consider widening the watchlist to other contractors and material producers linked to 33 best rare earth metal stocks.

NYSE:LMT Earnings & Revenue Growth as at Nov 2026
NYSE:LMT Earnings & Revenue Growth as at Nov 2026

Lockheed Martin is one of the largest aerospace and defense contractors globally, supplying missile, aircraft, and space systems to governments across regions including the United States, Europe, Asia, and the Middle East. As a result, any change in its manufacturing footprint or access to rare earths can shape how reliably it delivers those programs.

5 things going right for Lockheed Martin that this headline doesn't cover.

How do the Camden and ARRW facility projects fit into Lockheed Martin’s wider growth push?

The US$420 million Camden expansion and the ARRW build out in Troy both point to a single direction: higher throughput on missiles and hypersonics. Lockheed Martin is already committing US$8b to US$9b of investment through 2030 to meet munitions demand, with ARRW alone tied to a US$694 million Air Force contract and a tripling of Troy’s production space.

Does this rare earths news change the Lockheed Martin Narrative investors have been using?

The Army’s move to secure a 75 year rare earth processing lease speaks directly to the Narrative’s focus on supply chain security for PAC 3, THAAD, PrSM and other missile programs under seven year frameworks. It supports the idea that production risk is easing, while the key overhang in the Narrative remains U.S. budget and funding decisions rather than access to critical materials.

See how these catalysts shape Lockheed Martin's path to a $645 fair value.

What should investors watch next to see if this actually moves the needle for Lockheed Martin?

The clearest checkpoint is how these expansions show up in segment numbers and guidance through 2027, especially Missiles and Fire Control output and margins relative to the raised 2026 sales range of US$80b to US$82b. Any detail on realized PAC 3, THAAD and ARRW production rates, plus progress on the Army’s rare earths agreement, will show whether the capacity and materials bets are paying off.

One more Lockheed Martin piece that rarely makes the headlines

Investors have seen where Lockheed Martin builds missiles and where it might source critical materials, but not who sets those priorities at the top or how their pay packages are structured. See who is actually steering Lockheed Martin, and how they are paid.